Toggle navigation
TWunroll
TWunroll
faq
Contact US
#COVISHIELD
dwai banerjee
dwai_banerjee
To friends in India. Based on my decade of research on drug regulations and safety in India, here's my takeaway on the two Covid vaccines available. if you can get
Read more
Aryj
Arrryj
It's okay to be concerned about the COVID-19 vaccines. But concern means you learn about them, and do some credible research or ask experts who'd be able to answer the
Read more
covid19indiaorg
covid19indiaorg
The expert committee of CDSCO met on 30/12, 01/01 and 02/01 to deliberate on accelerated approval of vaccines. Recommendations made on each day have been officially published. In this thread,
Read more
Hitanshu Gandhi
free_rider
Read it in reverseWhen we know that Covaxin is effective in generating the immune system response and cases are surging and Covishield volume isn't enough, then it is better to
Read more
Murad Banaji
muradbanaji
Mumbai #COVID19 update. The epidemic refuses to die away. The city is still generating about 500 cases daily. That's almost 5% of the national total, and despite many restrictions still
Read more
Saurabh Joglekar (सौरभ जोगळेकर)
joglekarsaurabh
#Pune has a proven track record of high quality standards in education & ease of living; with culture, heritage & traditions intact. Pune has responded to this Pandemic situation like no
Read more
Anupam Singh
anupampom
Very important study with implications 4 India1. Novavax Vaccine (being manufactured by COVOVAX by Serum Institute) has 89% efficacy in UK trial ( normal and UK Variant ) n 60%
Read more
Anupam Singh
anupampom
Currently Vaccination are being done at ~ 3 Lakh per day. Ratio is 9:1 for Covishield : Covaxin. Hence Covaxin is indeed being used as a "back up" in a
Read more
Dr Sumaiya Shaikh
Neurophysik
My analysis of the paper released by #BharatBiotech researchers & the Press Statement by the Drugs Controller General of India (DCGI) on Restricted Emergency approval of 1out of 3 COVID-19
Read more
Dr Sumaiya Shaikh
Neurophysik
In the light of various new homologous strains, in addition to the UK one, emerging globally, that may be evolved to escape the neutralising antibodies post vaccinations. It is in
Read more
Maneesh
Maneesh312
Curious case of Covishield in India.As we know how a “mistake” of wrong dose which otherwise vitiates the whole trial took the efficacy of Oxford AstraZeneca’s ChAdOx1-S from 60 %
Read more
Vishnu Som
VishnuNDTV
1. On Sunday, Maharashtra crossed 4000 Covid cases after 39 days. Mumbai reports 600 cases after a month. Covid hasn't disappeared. Every day of delaying the private availability of vaccines
Read more
Maneesh
Maneesh312
We have two vaccines in India Covishield by SII and Covaxin by BB. One is a botched up trial and another with no phase-3 trial data and phase 1 and
Read more
covid19indiaorg
covid19indiaorg
A (long) thread on Bharat Biotech - ICMR's #Covaxin vaccine.1. Type of vaccine: #Covaxin is a whole virion INACTIVATED vaccine.In such vaccines, the whole #sarscov2 virus is inactivated to make
Read more
Anant Bhan
AnantBhan
THE VACCINE DILEMMAThe government has announced an intent to go ahead with vaccination as of 16th Jan 2021 with both Covishield and Covaxin. There is going to be no choice.
Read more
Krishna kumar
kkumarkg
What I feel the Indian #CovidVaccine #vaccinations scene will be likeGovernment will used Oxford - AstraZeneca's #Covishield initially as the lead vaccine it is public vaccination program.Eventually, I expect #Covaxin
Read more
‹
1
2
3
›
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree